No abstract

Cervical cancer is the fourth most common cancer in women world-wide and the most common cancer in many low-and middle-income countries. 1 It is estimated that 84% of cervical cancer cases occur in less developed countries, where cervical cancer diagnostic screening and prevention methods are limited. To illustrate this disparity, Over time, the incidence of cervical cancer in developed markets has been reduced thanks to the use of Pap smears (Pap test) and subsequent treatments, but women living in rural areas and low-resource settings (LRS) worldwide lack access to these relatively straightforward lifesaving techniques, and the demands of the test are too complex for many low-resource countries. Based on this background, the critical role for